SEARCH RESULTS

331256 RESULTS

Mohammad Arif


Research Assistant Scientist
Staten Island, United States

CONCERT Trial of Dimebon Falls Flat

RESEARCH NEWS 2012-01-18 Research News Another Phase 3 trial of Dimebon has fallen flat. In the multicenter CONCERT trial, patients with mild to moderate Alzheimer’s disease who took 5 or 20 mg of Dimebon three times per day for 12 months, on top of the cholinesterase inhibitor d

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE